AnswersPublished21 sources
OpenAI Backs Bipartisan Biosecurity Bills and Independent AI Safety Reviews
OpenAI is backing three bipartisan biosecurity bills—the Web of Biological Data Act, AI Ready Bio Data Standards Act, and Scale Biology Act—plus a FRONTIER Act provision for independent model safety evaluators. The policy push reflects concern that increasingly capable AI could amplify biological risks, while OpenAI...
Published byEdited with GPT-5.6 TerraImages generated with GPT Image 2
Research answer
Key takeaways
- OpenAI is backing three bipartisan biosecurity bills—the Web of Biological Data Act, AI Ready Bio Data Standards Act, and Scale Biology Act—plus a FRONTIER Act provision for independent model safety evaluators.
- The policy push reflects concern that increasingly capable AI could amplify biological risks, while OpenAI argues voluntary commitments alone are no longer sufficient.
- OpenAI has not endorsed the FRONTIER Act in its entirety; its stated support is for the provision requiring leading AI companies to use independent evaluators.
AI Prompt
openai.comCreate a landscape editorial hero image for this Studio Global article: What bipartisan U.S. Congressional bills and provisions is OpenAI endorsing to reduce the risk that advanced AI models could accelerate biol. Article summary: OpenAI is backing a bipartisan, two-track congressional agenda: strengthen the biological-data and screening infrastructure needed to detect and counter AI-enabled pathogen risks, and impose independent safety scrutiny o. Topic tags: general, general web, news. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, watermarks, charts with fake numbers
OpenAI has endorsed a bipartisan set of U.S. congressional proposals intended to reduce the chance that advanced AI systems could accelerate biological-weapons or synthetic-virus threats. Its position has two connected parts: improve the data and research foundations for biosecurity, and require outside scrutiny of the most capable AI models. The endorsements concern bills pending before Congress—they do not mean the measures have been enacted. 17
23
The measures OpenAI is endorsing
OpenAI supports three bills focused on biological data and biosecurity capacity:
- Web of Biological Data Act
- AI-Ready Bio-Data Standards Act
- Scale Biology Act
Reporting on the endorsements describes the package as an effort to improve access to biological data needed to build defenses against synthetic and naturally occurring threats, while establishing standards for the safe development of those tools. 23 OpenAI says the goal is to help prevent AI models from accelerating the threat of biological weapons and synthetic viruses.
17
The company is also backing a specific provision in the bipartisan House FRONTIER Act. That provision would require leading AI companies to use independent evaluators to assess model safety. OpenAI’s support is for that outside-evaluation requirement, rather than a blanket endorsement of the full bill. 35
39
Why biological data and AI evaluations are being linked
The legislative package treats AI-biosecurity risk as a problem with two layers.
First, defensive systems need high-quality, accessible biological data and standards to help researchers and institutions identify and respond to biological threats. The three bio-data bills are aimed at that defensive infrastructure. 23
Second, model developers’ own safety claims should be examined by evaluators outside the company. OpenAI has argued that trusted third-party evaluations can provide additional evidence about frontier-model capabilities and the effectiveness of safety mitigations, helping uncover blind spots and improve transparency. 8
9
In practical terms, the policy approach does not rely solely on restricting a model after release. It also seeks stronger biological defenses and independent testing before dangerous capabilities can be misused at scale.
The wider concern about AI-enabled biological misuse
The endorsements come amid broader warnings that powerful AI systems may lower barriers to harmful biological activity. Anthropic said it identified and disrupted malicious use of its AI model that could support biological-weapons development. 19
Separately, a group of major AI executives—including OpenAI CEO Sam Altman, Anthropic CEO Dario Amodei, and Google DeepMind CEO Demis Hassabis—were reported to have signed a letter urging Congress to require safeguards for orders of synthetic DNA and RNA. 20 That call focused on screening and traceability at a critical point in the biotechnology supply chain.
These developments do not establish that AI has independently created a biological weapon. They do show why companies and policymakers are focusing on both model behavior and the surrounding systems that enable biological work.
How this fits OpenAI’s broader federal-safety agenda
OpenAI’s biosecurity endorsements are part of a larger call for national, capability-based regulation of the most advanced AI systems. In September, the company said it wanted to work with Congress on mandatory national AI safety requirements, arguing that the prospect of AI accelerating AI development requires more than voluntary commitments. 3
18
OpenAI has pointed to measures such as risk assessment, independent assessment, cybersecurity protections, and reporting of serious safety incidents as components of an accountable safety regime. 3
6
Jakub Pachocki, OpenAI’s chief scientist, has also called for voluntary slowdowns in AI development until adequate safeguards are in place, according to BBC reporting. 19
What OpenAI’s endorsements mean—and what they do not
The immediate takeaway is that OpenAI is supporting a layered federal approach:
- Strengthen biosecurity data and standards through the Web of Biological Data Act, AI-Ready Bio-Data Standards Act, and Scale Biology Act.
- Require independent safety review for leading AI developers through the FRONTIER Act provision it supports.
- Move toward binding national rules for frontier AI systems instead of relying only on voluntary company commitments.
17
35
That is a policy position, not a guarantee of legislative passage or proof that the proposed safeguards will eliminate biological misuse. But it makes clear that OpenAI sees AI-biosecurity as both a biology-infrastructure challenge and a frontier-model governance challenge.
Studio Global AI
Continue your research
This page includes a source-backed answer you can continue inside Studio Global.
People also ask
What is the short answer to "OpenAI Backs Bipartisan Biosecurity Bills and Independent AI Safety Reviews"?
OpenAI is backing three bipartisan biosecurity bills—the Web of Biological Data Act, AI Ready Bio Data Standards Act, and Scale Biology Act—plus a FRONTIER Act provision for independent model safety evaluators.
What are the key points to validate first?
OpenAI is backing three bipartisan biosecurity bills—the Web of Biological Data Act, AI Ready Bio Data Standards Act, and Scale Biology Act—plus a FRONTIER Act provision for independent model safety evaluators. The policy push reflects concern that increasingly capable AI could amplify biological risks, while OpenAI argues voluntary commitments alone are no longer sufficient.
What should I do next in practice?
OpenAI has not endorsed the FRONTIER Act in its entirety; its stated support is for the provision requiring leading AI companies to use independent evaluators.